Protagonist Therapeutics (PTGX) FCF Margin Growth (1y) (2018 - 2026)
Protagonist Therapeutics (PTGX) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Protagonist Therapeutics | 8.81 Bn | 8.81 Bn | - | -52,775.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52,775.00 |
| Dec 31, 2025 | -50,058.00 |
| Sep 30, 2025 | 57,338.00 |
| Jun 30, 2025 | -695,658.00 |
| Mar 31, 2025 | 45,158.00 |
| Dec 31, 2024 | -5,175.00 |
| Jun 30, 2022 | -55,074.00 |
| Mar 31, 2022 | 31,870.00 |
| Dec 31, 2021 | 2,213.00 |
| Sep 30, 2021 | -14,603.00 |
| Jun 30, 2021 | -72,266.00 |
| Mar 31, 2021 | -2,787.00 |
| Dec 31, 2020 | -97,890.00 |
| Sep 30, 2020 | 21,179.00 |
| Jun 30, 2020 | -38,160.00 |
| Mar 31, 2020 | 64,039.00 |
| Dec 31, 2019 | 107,612.00 |
| Sep 30, 2019 | -18,250.00 |
| Jun 30, 2019 | 16,788.00 |
| Mar 31, 2019 | -93,797.00 |